Biotech Values

[DewDiligence]

ZGEN prices public offering:

http://finance.yahoo.com/news/ZymoGenetics-Prices-Public-bw-245041974.html?x=0&.v=1

Assuming the underwriter’s 15% option is exercised in full, 16.1M shares will be sold at $6.00/sh for net proceeds of $90.8M after deducting the 6% underwriter’s fee.

(In the unlikely event the underwriter’s option is not exercised, the offering will be 14M shares for net proceeds of $79M.)

The share price fell 10% today to end up near the offering price, which is a typical outcome.